THU AM News: Archeus Technologies, WARF launching clinical trial this year...
— Archeus Technologies in Madison and WARF are launching a clinical trial this year for a targeting molecule used in treating prostate cancer. The organizations yesterday announced the plans to further develop ART-101, a receptor-based targeting molecule …